Navigation Links
Nanomedical Diagnostics Announces Partnership with Rogue Valley Microdevices, Delivering World’s First Successful High-Volume Manufacturing for Graphene Biosensors
Date:3/8/2017

Biotech company Nanomedical Diagnostics teams with full-service MEMS foundry Rogue Valley Microdevices to deliver the only mass-produced graphene biosensor available, AGILE R100. Previously, the benefits of graphene biosensor technology were restricted to specialized, well-funded university labs building one-off platforms. The new partnership between Nanomedical Diagnostics and Rogue Valley Microdevices has opened the novel sensing technique to any pharmaceutical company seeking to characterize biomolecules quickly and easily, transforming the field of drug discovery.

Graphene has been touted as the world’s most versatile material capable of revolutionizing biomedical applications due to its excellent electrical conductivity, high surface area, and unique biocompatibility. Studies on the detection of biomolecules using lab-produced graphene-based biosensors have shown the sensors to exhibit high sensitivities, wide linear detection ranges, and low detection limits. Numerous efforts have been made by companies to commercialize graphene biosensors at scale, but the process was hampered due to the difficulty of integrating delicate graphene material into standard high-volume production processes.

Nanomedical Diagnostics together with Rogue Valley Microdevices has solved the riddle, overcoming substantial manufacturing hurdles to bring the label-free kinetic binding assay AGILE R100 to market. AGILE R100 is designed to provide biophysical data to pharmaceutical and biotherapeutics companies seeking more informed decisions earlier in the drug discovery process. However, with the most difficult piece of the puzzle – cost-effective large-scale manufacturing – solved, the company plans a significant impact on the healthcare industry with innovative new products that enable cutting-edge life science research, drug discovery applications, and diagnostic and health monitoring platforms.

“Rogue Valley Microdevices has been a true partner in developing a viable large-scale fabrication process for our AGILE biosensor chips,” says Nanomedical Diagnostics founder and CEO, Ross Bundy. “Their world-class process engineers enabled AGILE R100 to be manufactured with high reproducibility, quality, and throughput, which provides better data and lower costs for our customers. In the long run, the ability to manufacture graphene biosensors at scale will enable us to create significant cost reductions for many life science and healthcare applications, as well as introduce game-changing capabilities that have never been seen before.”

“When Nanomedical Diagnostics approached us with the AGILE R100 design, we recognized the opportunity to get in on the ground floor of a revolution,” says Jessica Gomez, founder and CEO of Rogue Valley Microdevices. “We have codeveloped the only graphene biosensor fabrication process in existence and are now the pre-eminent experts in that field.”

Nanomedical Diagnostics will be at the 2017 American Chemistry Society National Meeting in San Francisco to present AGILE R100 and the unique graphene biosensor technology behind the platform. Visit booth 1434 from April 2 through 4 to learn more.

About Nanomedical Diagnostics

Nanomedical Diagnostics (“Nanomed”) is a biotech company based in San Diego, CA. Nanomed has developed a breakthrough electronic assay based on Field Effect Biosensing (FEB) technology that provides real-time, label-free kinetic binding and affinity data. Biosensors at the heart of the assay leverage the highly sensitive nanomaterial graphene to unite biology with electronics, delivering the unique ability to sense molecules >1 Da in complex media such as DMSO, and use unprecedentedly small amounts of sample.

About Rogue Valley Microdevices

Rogue Valley Microdevices is a full-service precision MEMS foundry that combines state-of-the-art process modules with the engineering expertise to go seamlessly from custom design to manufacturing. Specializing in MEMS and biomedical device manufacturing, Rogue Valley Microdevices offers a flexible equipment set and smaller batch sizes, playing a critical role in the commercial MEMS manufacturing ecosystem.

Read the full story at http://www.prweb.com/releases/Nanomedical_Diagnostics/graphene_biosensor/prweb14129892.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Nanomedical Diagnostics to Present Field Effect Biosensing for Fragment-Based Drug Discovery at SLAS 2017
2. Nanomedical Diagnostics CEO and CTO to Introduce Electronic Label-Free Assay Based on Field Effect Biosensing Technology at IDTechEx Show
3. Nanomedical Diagnostics launches a new graphene biosensor with unprecedented functionality for small molecule and protein analysis
4. Nanomedical Diagnostics Announces Scientific Advisory Board of Top Scientists and Medical Researchers
5. Global Licensing Partnering Report: Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016 - Research and Markets
6. SQI Diagnostics Reports First Quarter 2017 Results
7. Paradigm Diagnostics Announces $7M Series B Funding
8. Ortho Clinical Diagnostics Recognized with Two Global Business Excellence Awards
9. Global Biomarkers Technologies, Markets and Companies Report 2017-2025: Proteomics, Metabolomics, Molecular Diagnostics, Drug Discovery, Clinical Trials, and Bioinformatics - Research and Markets
10. Global Molecular Diagnostics Analysis Report 2010-2016: Deal Trends, Key Players, Top Deal Values & Deals Financials - Research and Markets
11. How These Business Services Stocks are Faring? -- Interpace Diagnostics, Convergys, HMS Holdings, and Priceline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
Breaking Biology Technology:
(Date:6/30/2017)... Va. , June 30, 2017 ... leading developer and supplier of face and eye ... ATA Featured Product provider program. ... an innovative way to monitor a driver,s attentiveness ... greatly from being able to detect fatigue and ...
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):